SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Q1 Trading Update

19 Apr 2018 07:00

RNS Number : 3888L
Rentokil Initial PLC
19 April 2018
 

 

RENTOKIL INITIAL PLC (RTO)

FIRST QUARTER TRADING UPDATE

19 April 2018

 

(£m)

 

Q1 2018

Growth

 

 

AER

AER

CER

Ongoing Revenue1

 

545.9

10.8%

15.7%

Revenue

 

550.7

-5.1%

-1.5%

 

Overview

Trading has started well across our businesses in Q1 with Ongoing Revenue increasing by 15.7%.

Organic Revenue2 Growth of 3.2% compares to Q1 2017 at 3.7%* (3.1% Reported) and Q4 2017 (3.1%). Organic growth has been affected by the ongoing impact of last September's hurricane on our operations in Puerto Rico (as previously highlighted at the time of our Preliminary results) and unseasonably cold weather in the US in March which has delayed the onset of the spring pest season. Excluding the impact of Puerto Rico, 2018 Q1 Organic growth is in line with Q1 2017.

Acquisitions have performed well contributing 12.5% to Ongoing Revenue in the first quarter.

Ongoing Revenue in Pest Control grew by 15.8% (4.7% Organic, Q1 2017: 5.6%, Q4 2017: 4.9%) with Growth markets growing by 12.4% and Emerging markets increasing by 38.2%, reflecting the strong performance of our joint venture in India.

Q1 2018 Hygiene Ongoing Revenue rose by 29.3% (1.8% Organic, Q1 2017: 3.4%, Q4 2017: -0.2%), driven by the acquisitions of Cannon Hygiene and CWS Italy.

Ongoing Revenue in our Protect & Enhance markets declined by -0.1% (-0.3 Organic, Q1 2017: -0.9%, Q4 2017: 1.0%) due to ongoing market weakness in our UK Property Care business, offset by a stronger performance from our French business.

While currency markets remain volatile, our guidance for the adverse impact of foreign exchange on profit is in the range of £10m to £15m for the year, as previously guided at the Preliminary results on 1 March 2018.

M&A 

​In the three months to 31 March 2018 we made 11 pest control acquisitions (five in North America with annualised revenues of $27m) in addition to the Cannon Hygiene businesses acquired in January. Combined annualised revenues of the 12 businesses acquired was £103.0m in the year prior to purchase. Our guidance for M&A spend remains in the range of £200m to £250m which will be funded by cash held on the balance sheet at the beginning of the year. We are encouraged about our prospects for further M&A this year and our pipeline of value-enhancing opportunities is strong.

Commenting on today's announcement Andy Ransom, Chief Executive, said:

"I am pleased with our performance in Q1 and we are well-positioned for another year of successful growth. We are confident that the Company will deliver a performance in line with market expectations for 2018."

 

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

 

 

 

 

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

 

 

 

 

 

 

 

 

1Ongoing Revenue represents the performance of the continuing operations of the Group (including acquisitions) after removing the effect of disposed or closed businesses.

 

2Organic Revenue represents the growth in Ongoing Revenue excluding the effect of businesses acquired during the year. Acquired businesses are included in organic measures in the year following acquisition, and the comparative period is adjusted to include an estimated full year performance for growth calculations.

 

*In Q1 2017 the Company reported Organic growth of 3.1% in Q1 but noted that excluding the businesses transferred to the Haniel JV, the Organic growth figure would have been 3.5%. We have further adjusted this number to exclude the eight French flat linen laundries sold to RLD in H2 2017, which results in a revised comparative number for Q1 2017 of 3.7%.

 

AER - actual exchange rates; CER - constant 2017 exchange rates

 

This announcement contains statements that are, or may be, forward-looking regarding the Group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure Guidance and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMMGMDNRFGRZM
Date   Source Headline
19th Jul 20177:00 amRNSAppointment of Non-Executive Director
30th Jun 20178:33 amRNSCompletion of Joint Venture with Haniel
27th Jun 20175:21 pmRNSHolding(s) in Company
26th Jun 20174:54 pmRNSHolding(s) in Company
8th Jun 201711:40 amRNSFurther re Joint Venture with Haniel
7th Jun 20179:41 amRNSDirector Declaration
17th May 20175:02 pmRNSHolding(s) in Company
10th May 20174:31 pmRNSResult of AGM
10th May 20174:03 pmRNSHolding(s) in Company
10th May 201711:49 amRNSAppointment of Senior Independent Director
9th May 20175:51 pmRNSHolding(s) in Company
4th May 20174:44 pmRNSDirector/PDMR Shareholding
26th Apr 20174:27 pmRNSDirector/PDMR Shareholding
25th Apr 20175:58 pmRNSDirector/PDMR Shareholding
21st Apr 20177:00 amRNSRentokil awarded Queen's Award for Enterprise
19th Apr 20177:00 amRNSQ1 Trading Update
5th Apr 201710:43 amRNSAnnual Financial Report
31st Mar 20174:18 pmRNSTotal Voting Rights
30th Mar 20173:25 pmRNSBlock listing Interim Review
22nd Mar 20176:10 pmRNSHolding(s) in Company
9th Mar 20173:06 pmRNSAdditional Listing
28th Feb 20177:00 amRNSRentokil - Leading Pest Control Company in India
24th Feb 20172:37 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSFinal Results
7th Feb 20177:00 amRNSAcquisition of Allgood Pest Solutions
29th Dec 20164:30 pmRNSDirector/PDMR Shareholding
16th Dec 20162:59 pmRNSHolding(s) in Company
16th Dec 20162:02 pmRNSHolding(s) in Company
16th Dec 20167:00 amRNSJoint venture with Haniel
7th Dec 20165:47 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSHolding(s) in Company
18th Nov 20161:15 pmRNSDirector Declaration
11th Nov 20165:30 pmRNSHolding(s) in Company
11th Nov 20165:10 pmRNSTotal Voting Rights
3rd Nov 20161:01 pmRNSDirector Declaration
19th Oct 20167:00 amRNSQ3 Trading Update
6th Oct 20162:58 pmRNSAdditional Listing
6th Oct 201612:31 pmRNSDirector Declaration
4th Oct 20169:49 amRNSDirector Declaration
30th Sep 20162:10 pmRNSTotal Voting Rights
29th Sep 20167:00 amRNSAdditional Listing
26th Sep 20164:48 pmRNSDirector/PDMR Shareholding
22nd Aug 20164:56 pmRNSHolding(s) in Company
28th Jul 20167:00 amRNSHalf Yearly Report
27th Jul 20167:00 amRNSCollaboration with Google and PA Consulting Group
7th Jul 20167:00 amRNSAcquisition, CDC Contract Win and Trading Update
29th Jun 20167:00 amRNSDirectorate Change
29th Jun 20167:00 amRNSDirector/PDMR Shareholding
22nd Jun 20165:27 pmRNSHolding(s) in Company
17th May 20165:06 pmRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.